Should Cannabis Investors Be Starting to Sweat?

Down more than 70% in the last 12 months, the brutal fall of the industry-tracking AdvisorShares Pure U.S. Cannabis ETF (NYSEMKT: MSOS) is an undeniable sign that cannabis stocks are enormously struggling. Leading companies like Tilray Brands (NASDAQ: TLRY), Trulieve Cannabis, and Cresco Labs are reporting shrinking quarterly earnings compared to a year ago, and their struggles with becoming and remaining profitable are as pronounced as ever. If you're a cannabis investor and the above doesn't bother you, it probably should, as there are a handful of factors like market saturation driving the declines in top lines and stock prices alike.